Host-microbial interactions in idiopathic pulmonary fibrosis
File(s)blue_ipf_expression_microbiome_Revised.docx (307.89 KB)
Accepted version
Author(s)
Type
Journal Article
Abstract
RATIONALE: Changes in the respiratory microbiome are associated with disease progression in Idiopathic pulmonary fibrosis (IPF). The role of the host response to the respiratory microbiome however remains unknown. OBJECTIVES: To explore the host-microbial interaction in IPF. METHODS: Sixty patients diagnosed with IPF were prospectively enrolled, together with 20 matched controls. Subjects underwent bronchoalveolar lavage (BAL) and peripheral whole blood was collected into PAXgene tubes for all subjects at baseline. For IPF subjects additional samples were taken at 1, 3, and 6 months and (if alive) a year. Gene expression profiles were generated using Affymetrix Human Gene1.1ST Arrays. MEASUREMENTS AND MAIN RESULTS: Network analysis of gene expression data identified two gene modules that strongly associate with a diagnosis of IPF, BAL bacterial burden (determined by 16S quantitative PCR) and specific microbial OTUs, as well as lavage and peripheral blood neutrophilia. Genes within these modules that are involved in the host defence response include NLRC4, PGLYRP1, MMP9, DEFA4. The modules also contain two genes encoding specific antimicrobial peptides (SLPI and CAMP). Many of these particular transcripts were associated with survival and showed longitudinal over expression in subjects experiencing disease progression, further strengthening their relationship with disease. CONCLUSIONS: Integrated analysis of the host transcriptome and microbial signatures demonstrates an apparent host response to the presence of an altered or more abundant microbiome. These responses remain elevated on longitudinal follow up, suggesting that the bacterial communities of the lower airways may be acting as persistent stimuli for repetitive alveolar injury in IPF.
Date Issued
2017-06-15
Date Acceptance
2017-01-11
Citation
American Journal of Respiratory and Critical Care Medicine, 2017, 195 (12), pp.1640-1650
ISSN
1535-4970
Publisher
American Thoracic Society
Start Page
1640
End Page
1650
Journal / Book Title
American Journal of Respiratory and Critical Care Medicine
Volume
195
Issue
12
Copyright Statement
© 2017 the American Thoracic Society.
Sponsor
British Lung Foundation
Wellcome Trust
Wellcome Trust
National Institute for Health Research
Medical Research Council (MRC)
Medical Research Council (MRC)
National Institute for Health Research
Identifier
http://www.ncbi.nlm.nih.gov/pubmed/28085486
Grant Number
BLF-RMF 15-16
096964/Z/11/Z
097117/Z/11/Z
BRU 6279
G1000758
G1000758
NF-SI-0512-10126
Subjects
Science & Technology
Life Sciences & Biomedicine
Critical Care Medicine
Respiratory System
General & Internal Medicine
usual interstitial pneumonia
acute lung injury
microbiome
idiopathic pulmonary fibrosis
expression
MUC5B PROMOTER POLYMORPHISM
FACTOR-KAPPA-B
LUNG INJURY
NETWORKS
DISEASE
PHOSPHORYLATION
SUSCEPTIBILITY
EXACERBATION
PATHOGENESIS
ASSOCIATION
acute lung injury
expression
idiopathic pulmonary fibrosis
microbiome
usual interstitial pneumonia
Aged
Bronchoalveolar Lavage Fluid
Female
Follow-Up Studies
Host-Pathogen Interactions
Humans
Idiopathic Pulmonary Fibrosis
Male
Microbiota
Prospective Studies
Transcriptome
Bronchoalveolar Lavage Fluid
Humans
Follow-Up Studies
Prospective Studies
Aged
Female
Male
Host-Pathogen Interactions
Idiopathic Pulmonary Fibrosis
Transcriptome
Microbiota
Respiratory System
11 Medical and Health Sciences
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2017-01-13